Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents

Author： Guerra Iván   Gisbert Javier P  

Publisher： Informa Healthcare

ISSN： 1747-4124

Source： Expert Review of Gastroenterology and Hepatology, Vol.7, Iss.1, 2013-01, pp. : 41-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategic Use of Immunosuppressants and Anti-TNF in Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 31, Iss. 2, 2013-09 ,pp. : 207-212

Karger

Access to resources Recommend Favorite

Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 33, Iss. 1, 2015-09 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Induction or Exacerbation of Psoriasis in Patients with Crohn's Disease under Treatment with Anti-TNF Antibodies

By  

Digestion, Vol. 89, Iss. 3, 2014-05 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

Anti-inflammatory and anti-atherogenic effects of adiponectin in patients with rheumatoid arthritis following anti-TNF therapy

By Kapoor S.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 2, 2009-01 ,pp. : 158-158

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of the anti-TNF biologic agents

By Weaver Arthur L.  

Modern Rheumatology, Vol. 14, Iss. 2, 2004-06 ,pp. : 101-112

Springer Publishing Company

Access to resources Recommend Favorite